These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2459808

  • 1. Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies.
    Rothman SW, Gentry MK, Brown JE, Foret DA, Stone MJ, Strickler MP.
    Toxicon; 1988; 26(6):583-97. PubMed ID: 2459808
    [Abstract] [Full Text] [Related]

  • 2. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
    Lyerly DM, Phelps CJ, Toth J, Wilkins TD.
    Infect Immun; 1986 Oct; 54(1):70-6. PubMed ID: 2428753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
    Fu SW, Zhou DY, Lai ZS, Xue J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
    Padhye VV, Zhao T, Doyle MP.
    J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
    [Abstract] [Full Text] [Related]

  • 7. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity.
    Kamiya S, Yamakawa K, Meng XQ, Ogura H, Nakamura S.
    FEMS Microbiol Lett; 1991 Jul 01; 65(3):311-5. PubMed ID: 1916231
    [Abstract] [Full Text] [Related]

  • 8. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
    von Eichel-Streiber C, Harperath U, Bosse D, Hadding U.
    Microb Pathog; 1987 May 01; 2(5):307-18. PubMed ID: 2467163
    [Abstract] [Full Text] [Related]

  • 9. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.
    Frey SM, Wilkins TD.
    Infect Immun; 1992 Jun 01; 60(6):2488-92. PubMed ID: 1375199
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A, Keusch GT, Edson C, Thorley-Lawson D, Jacewicz M.
    J Exp Med; 1984 Dec 01; 160(6):1767-81. PubMed ID: 6392471
    [Abstract] [Full Text] [Related]

  • 11. Characterization of six murine monoclonal antibodies specific for toxin B of Clostridium difficile.
    Coughlin RT, Annunziato M, Roberson J, Marciani DJ.
    Hybridoma; 1994 Apr 01; 13(2):147-52. PubMed ID: 8050780
    [Abstract] [Full Text] [Related]

  • 12. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W, Liu WE, Li YM, Luo S, Zhong YM.
    Mol Med Rep; 2015 Nov 01; 12(5):7712-20. PubMed ID: 26459027
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G, Muller MC, Wilkins TD, Lyerly D, L'Haridon R.
    Infect Immun; 1991 Mar 01; 59(3):1192-5. PubMed ID: 1900059
    [Abstract] [Full Text] [Related]

  • 16. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M, Holmgren J, Schödel F, Lebens M.
    Gene; 1995 Nov 20; 165(2):163-71. PubMed ID: 8522171
    [Abstract] [Full Text] [Related]

  • 17. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF, Monath TP.
    J Med Microbiol; 1996 Jun 20; 44(6):464-74. PubMed ID: 8636964
    [Abstract] [Full Text] [Related]

  • 18. Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization.
    Zhang C, Jin K, Xiao Y, Cheng Y, Huang Z, Wang S, Lu S.
    Hum Vaccin Immunother; 2013 Oct 20; 9(10):2157-64. PubMed ID: 23851482
    [Abstract] [Full Text] [Related]

  • 19. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
    Wang S, Rustandi RR, Lancaster C, Hong LG, Thiriot DS, Xie J, Secore S, Kristopeit A, Wang SC, Heinrichs JH.
    Vaccine; 2016 Mar 04; 34(10):1319-23. PubMed ID: 26614590
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of monoclonal antibodies to Shiga toxin.
    Griffin DE, Gentry MK, Brown JE.
    Infect Immun; 1983 Jul 04; 41(1):430-3. PubMed ID: 6345399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.